Join Night Vision Disturbance Clinical Trials Focused on Improving Low-Light Vision After Refractive Surgery

These clinical trials are research studies evaluating investigational treatments designed to improve visual performance in low-light conditions for individuals experiencing symptoms such as glare, halos, starbursts, or reduced night vision.

Adults 18 years of age or older, who previously underwent keratorefractive surgery and continue to experience night vision symptoms may be eligible, depending on specific study requirements.

It refers to visual symptoms that occur in low-light environments, including difficulty seeing clearly at night, glare, halos around lights, and reduced visual sharpness.

Participants take the study medication or placebo once daily for two weeks, attend scheduled clinic visits (2 clinic visits over 14 days), complete vision testing, and receive ongoing safety monitoring.

The goal is to evaluate whether an investigational ophthalmic solution can safely improve visual acuity and overall visual performance under low-light conditions.

Participant safety is the top priority. The study follows strict regulatory and ethical standards, and all participants are closely monitored throughout. As with any investigational treatment, participants are informed of potential risks before enrolling.